September 11th, 2014
Is This Trial Ethical?
Current ALCS guidelines contain a Class IIb, level A recommendation for administration of epinephrine for sustained VF and PEA/asystole but acknowledge that although epinephrine treatment has been demonstrated to increase rates of return of spontaneous circulation, it has not been shown to improve long-term survival.
This is not the first time epinephrine and placebo have been compared in a randomized trial; results of such a trial appeared in Resuscitation in 2011. Nonetheless, the new trial appears to have sparked ethical concerns about its delayed-consent procedure.
What do you think? Would you support such a trial in your EMS system?
Comments are closed.
- Does Catheter Ablation Reduce Depression and Anxiety in Patients with Atrial Fibrillation?
- Adaptive Cardiac Resynchronization Therapy Fares No Better Than Conventional CRT
- Redo Transcatheter Aortic Valve Replacement Appears to Be Safe and Effective
- Managing Atrial Fibrillation During Acute Hospitalization
- Fluoroquinolones and the Risk for Aortic Aneurysm or Dissection: Should We Be Less Worried?
Sign up for NEJM Journal Watch Cardiology Alerts
Receive a free weekly email with the latest summaries on Cardiology.
- ACS AF AHA anticoagulation aortic valve replacement apixaban aspirin atrial fibrillation CABG cardiovascular risk cholesterol clopidogrel dabigatran diabetes diet drug-eluting stents epidemiology ESC exercise FDA FDA approvals Fellowship training guidelines HDL heart failure hypertension ICDs MI myocardial infarction obesity PCI Primary PCI risk factors rivaroxaban statins STEMI stents stroke stroke prevention TAVI TAVR type 2 diabetes venous thromboembolism warfarin women